Literature DB >> 9677593

[Possibilities of therapeutic photokeratotomy with the excimer laser in treatment of Schnyder crystalline corneal dystrophy].

U Meier, C Anastasi, F Failla, F Simona.   

Abstract

PURPOSE: To evaluate the efficacy of excimer laser phototherapeutic keratectomy (PTK) in treating the Schnyder cristalline corneal dystrophy.
METHODS: We examined the members of three generations of a family affected by Schnyder crystalline dystrophy. Two patients with disabling visual acuity were treated with PTK.
RESULTS: The best corrected visual acuity (BCVA) of the patient with the cristalline form of the dystrophy progressed from 20/70 to 20/25. The BCVA of the other patient affected by the sine crystals form of the Schnyder dystrophy progressed from 20/70 to 20/30.
CONCLUSIONS: Excimer laser photokeratectomy is a valuable tool in treating the Schnyder cristalline form of corneal dystrophy.

Entities:  

Mesh:

Year:  1998        PMID: 9677593     DOI: 10.1055/s-2008-1034920

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  [Schnyder's crystalline corneal dystrophy. Further narrowing of the linkage interval at chromosome 1p34.1-p36?].

Authors:  P Riebeling; S Polz; F Tost; J S Weiss; H Kuivaniemi; M Hoeltzenbein
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

2.  Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy.

Authors:  Andrew Orr; Marie-Pierre Dubé; Julien Marcadier; Haiyan Jiang; Antonio Federico; Stanley George; Christopher Seamone; David Andrews; Paul Dubord; Simon Holland; Sylvie Provost; Vanessa Mongrain; Susan Evans; Brent Higgins; Sharen Bowman; Duane Guernsey; Mark Samuels
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

3.  Functional study of SCCD pathogenic gene UBIAD1 (Review).

Authors:  Jumin Xie; Lingxing Li
Journal:  Mol Med Rep       Date:  2021-08-09       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.